Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development
The Prostate2005Vol. 64(1), pp. 92–100
Citations Over TimeTop 10% of 2005 papers
Hitoshi Ishiguro, Noboru Nakaigawa, Yasuhide Miyoshi, Kiyoshi Fujinami, Yoshinobu Kubota, Hiroji Uemura
Abstract
The AGE-RAGE interaction is important in prostate cancer development, and inhibition of this interaction has potential as a new molecular target for cancer therapy or prevention.
Related Papers
- → Antiproliferative effect of polyphenols and sterols of virgin argan oil on human prostate cancer cell lines(2006)83 cited
- Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy.(2015)
- → A comparative study on proteomics between LNCap and DU145 cells by quantitative detection and SELDI analysis(2008)2 cited
- Comparative gene expression related to the uptake of PET radiotracers in prostate cancer cell lines(2012)
- → Abstract 1581: Crosstalk of androgen sensitive prostate cancer cells and insensitive prostate cancer cells(2016)